Diamond Hill Capital Management Inc. Buys 16,911 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Diamond Hill Capital Management Inc. increased its stake in Astrana Health, Inc. (NASDAQ:ASTH) by 11.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 159,211 shares of the company’s stock after purchasing an additional 16,911 shares during the quarter. Diamond Hill Capital Management Inc. owned approximately 0.28% of Astrana Health worth $5,020,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. Swiss National Bank raised its holdings in shares of Astrana Health by 1.1% in the 4th quarter. Swiss National Bank now owns 88,444 shares of the company’s stock worth $2,789,000 after purchasing an additional 1,000 shares during the period. Moran Wealth Management LLC raised its holdings in shares of Astrana Health by 21.5% in the 4th quarter. Moran Wealth Management LLC now owns 7,944 shares of the company’s stock worth $250,000 after purchasing an additional 1,404 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Astrana Health by 348.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company’s stock worth $1,191,000 after purchasing an additional 29,355 shares during the period. Victory Capital Management Inc. raised its holdings in shares of Astrana Health by 38.6% in the 4th quarter. Victory Capital Management Inc. now owns 62,116 shares of the company’s stock worth $1,959,000 after purchasing an additional 17,310 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Astrana Health by 5.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company’s stock worth $14,861,000 after purchasing an additional 23,533 shares during the period. Institutional investors own 52.77% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Truist Financial reduced their price objective on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Stifel Nicolaus reduced their price objective on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Bank of America reduced their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th. Finally, Robert W. Baird reduced their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Astrana Health currently has an average rating of “Moderate Buy” and an average price target of $56.83.

Astrana Health Stock Up 0.5 %

ASTH opened at $29.34 on Friday. The company has a fifty day moving average price of $34.02 and a 200-day moving average price of $43.27. The firm has a market capitalization of $1.65 billion, a P/E ratio of 22.57, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health, Inc. has a one year low of $23.12 and a one year high of $63.20.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Equities research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.